High PDGFRA expression does not serve as an effective therapeutic target in ERG-deleted B-cell precursor acute lymphoblastic leukemia

• Isabel S. Jerchel,
• Danai Chatzivasileiou,
• Alex Q. Hoogkamer,
• Judith M. Boer,
• H. Berna Beverloo,
• Rob Pieters,
• Monique L. den Boer

Affiliations

Isabel S. Jerchel

Department of Pediatric Oncology, Erasmus Medical Center-Sophia Children’s Hospital, Rotterdam, the Netherlands

Danai Chatzivasileiou

Department of Pediatric Oncology, Erasmus Medical Center-Sophia Children’s Hospital, Rotterdam, the Netherlands

Alex Q. Hoogkamer

Department of Pediatric Oncology, Erasmus Medical Center-Sophia Children’s Hospital, Rotterdam, the Netherlands

Judith M. Boer

Department of Pediatric Oncology, Erasmus Medical Center-Sophia Children’s Hospital, Rotterdam, the Netherlands

H. Berna Beverloo

Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, the Netherlands

Rob Pieters

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands

Monique L. den Boer

Department of Pediatric Oncology, Erasmus Medical Center-Sophia Children’s Hospital, Rotterdam, the Netherlands